Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan.

Allogeneic hematopoietic cell transplantation Late effects Long-term follow-up Survivorship Transition

Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
05 2020
Historique:
received: 18 11 2019
revised: 22 12 2019
accepted: 11 01 2020
pubmed: 22 1 2020
medline: 24 6 2021
entrez: 22 1 2020
Statut: ppublish

Résumé

With increasing focus on the importance of long-term survivorship care after allogeneic hematopoietic cell transplantation (allo-HCT), more institutions have been establishing long-term follow-up (LTFU) clinics. Currently, however, with varying volumes of HCT procedures and resources, there is no standardized operation of these clinics in HCT centers. We conducted a nationwide questionnaire survey to characterize the current operation of LTFU clinics in Japan. We targeted 271 HCT centers (189 adult and 82 pediatric) that registered allo-HCT cases to the national transplant registry database. The response rate was 69%, and 117 of the 188 participating centers (62%) had an established LTFU clinic. The most frequent reason cited for not operating an LTFU clinic was a "lack of human resources," especially nurses. Most centers with an LTFU clinic targeted allo-HCT recipients, although autologous HCT survivors were followed up at 18% of adult centers and 48% of pediatric centers. Ninety-two percent of centers did not terminate LTFU at a specific time point, and 56% recommended that patients visit the LTFU clinic beyond 5 years after HCT. Fifteen of 20 pediatric centers indicated that they did not routinely refer survivors who underwent HCT at a young age to an adult HCT center for their adulthood LTFU. We found that staffing and standard practices varied widely among centers, and that most centers continued to see long-term HCT survivors at their own outpatient clinics. The development of common LTFU tools may help standardize LTFU practices and facilitate efficient transitions.

Identifiants

pubmed: 31962164
pii: S1083-8791(20)30019-7
doi: 10.1016/j.bbmt.2020.01.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

949-955

Informations de copyright

Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Saiko Kurosawa (S)

Department of Oncology, Ina Central Hospital, Ina, Japan; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. Electronic address: skurosaw@ncc.go.jp.

Ayako Mori (A)

Nursing Division, National Cancer Center Hospital, Tokyo, Japan.

Mayumi Tsukagoshi (M)

Nursing Division, National Cancer Center Hospital, Tokyo, Japan; Nursing Division, International University of Health and Welfare Hospital, Tochigi, Japan.

Yasushi Onishi (Y)

Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.

Chikako Ohwada (C)

Department of Hematology, Chiba University Hospital, Chiba, Japan.

Takehiko Mori (T)

Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Hideki Goto (H)

Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.

Yuki Asano-Mori (Y)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Yuichiro Nawa (Y)

Division of Hematology, Ehime Prefectural Central Hospital, Ehime, Japan.

Masayuki Hino (M)

Department of Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Tomoko Fukuchi (T)

Nursing Division, Osaka Women's and Children's Hospital, Osaka, Japan.

Yasuo Mori (Y)

Unit for stem cell transplantation and cell therapy, Kyushu University Hospital, Fukuoka, Japan.

Reiko Yamahana (R)

Chiba Faculty of Nursing, Tokyo Healthcare University, Chiba, Japan.

Yoshihiro Inamoto (Y)

Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.

Takahiro Fukuda (T)

Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH